This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, M. R. Articles by Bobik, A. Search for Related Content PubMed PubMed Citation Articles by Ward, M. R. Articles by Bobik, A.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:2461-2470.)
© 1997 American Heart Association, Inc.

Articles

Inhibition of Protein Tyrosine Kinases Attenuates Increases in Expression of Transforming Growth Factor-ß Isoforms and Their Receptors Following Arterial Injury

Michael R. Ward; Alex Agrotis; Peter Kanellakis; Rodney Dilley; Garry Jennings; ; Alex Bobik

From the Cell Biology Laboratory, Baker Medical Research Institute, and Alfred Baker Medical Unit, Alfred Hospital, Prahran, Australia.

Correspondence to Dr M. Ward, Cell Biology Laboratory, Baker Medical Research Institute, Commercial Rd, Prahran, VIC 3181, Australia. E-mail mward{at}Baker.edu.au

Abstract Transforming growth factor-ß₁ (TGF-ß₁) has been implicated in neointima formation in mechanically injured vessels and in restenosis after angioplasty. To further understand the significance of TGF-ßs in neointima formation, we examined the temporal expression of three TGF-ß isoforms (-ß₁, -ß₂, and -ß₃), their receptors (ALK-2, ALK-5, and TßRII), and two putative TGF-ß responses (elevations in _v and ß₃ integrin mRNAs) in balloon catheter–injured rat carotid arteries and their dependency on tyrosine kinase activity. Using a standardized reverse transcriptase–polymerase chain reaction assay optimized to estimate mRNA levels, we observed distinct patterns of mRNA regulation for TGF-ß₁, -ß₂, and -ß₃ during the 48 hours immediately after injury, which were localized to the vessel's media. TGF-ß₁ mRNA increased 10-fold during this time while TGF-ß₃ mRNA also increased almost 2-fold. There were also increases in mRNAs encoding the TGF-ß type I receptors ALK-5 and ALK-2, as well as the type II receptor (TßRII). Eight hours after the injury, mRNA levels for ALK-2 and ALK-5 were on average 2-fold higher; mRNA encoding the type II receptor increased approximately 3-fold by 24 hours. There were also associated increases in TGF-ß₁, TGF-ß₃, ALK-5, and TßRII immunoreactive peptide levels. Peak increases in mRNAs for integrins _v and ß₃ averaged approximately 2-fold and 2.5-fold, respectively. Perivascular administration of the tyrosine kinase inhibitor genistein at the time of vessel injury markedly (>85%) inhibited elevations in mRNAs encoding TGF-ß₁, TGF-ß₃, TßRII, and the two integrins _v and ß₃, while application of its inactive chemically similar homologue daidzein did not prevent the injury-induced elevations in mRNA levels. Since the increases in integrins _v and ß₃ mRNA could be theoretically attributed to TGF-ß actions despite being dependent on tyrosine kinase activity, we examined whether the observed elevations in integrins _v and ß₃ were due to TGF-ß₁ secretion, using cultured rat carotid artery smooth muscle cells. TGF-ß₁ neutralizing antibodies specifically inhibited elevations in integrins _v and ß₃ mRNAs due to platelet-derived growth factor-BB and fibroblast growth factor-2. We conclude that multiple components of the TGF-ß system in vessels are activated following injury and influence expression of integrin receptors important for smooth muscle cell migration. Activation of the TGF-ß system appears to be highly dependent on tyrosine kinases.

Key Words: transforming growth factor-ß • receptors • integrins _v and ß₃ • protein tyrosine kinase inhibitors • balloon catheter injury

This article has been cited by other articles:

				R. Khan, A. Agrotis, and A. Bobik Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury Cardiovasc Res, May 1, 2007; 74(2): 223 - 234. [Abstract] [Full Text] [PDF]

				M. Joner, A. Farb, Q. Cheng, A. V. Finn, E. Acampado, A. P. Burke, K. Skorija, W. Creighton, F. D. Kolodgie, H. K. Gold, et al. Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting Transforming Growth Factor-{beta} and MCP-1 Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 182 - 189. [Abstract] [Full Text] [PDF]

				A. Bobik Transforming Growth Factor-{beta}s and Vascular Disorders Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1712 - 1720. [Abstract] [Full Text] [PDF]

				Y. Asano, H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki Increased Expression of Integrin {alpha}v{beta}3 Contributes to the Establishment of Autocrine TGF-{beta} Signaling in Scleroderma Fibroblasts J. Immunol., December 1, 2005; 175(11): 7708 - 7718. [Abstract] [Full Text] [PDF]

				I. Woclawek-Potocka, T. J. Acosta, A. Korzekwa, M. M. Bah, M. Shibaya, K. Okuda, and D. J. Skarzynski Phytoestrogens Modulate Prostaglandin Production in Bovine Endometrium: Cell Type Specificity and Intracellular Mechanisms Experimental Biology and Medicine, May 1, 2005; 230(5): 326 - 333. [Abstract] [Full Text] [PDF]

				N. Kalinina, A. Agrotis, Y. Antropova, G. DiVitto, P. Kanellakis, G. Kostolias, O. Ilyinskaya, E. Tararak, and A. Bobik Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2320 - 2325. [Abstract] [Full Text] [PDF]

				A. Agrotis, P. Kanellakis, G. Kostolias, G. Di Vitto, C. Wei, R. Hannan, G. Jennings, and A. Bobik Proliferation of Neointimal Smooth Muscle Cells after Arterial Injury: DEPENDENCE ON INTERACTIONS BETWEEN FIBROBLAST GROWTH FACTOR RECEPTOR-2 AND FIBROBLAST GROWTH FACTOR-9 J. Biol. Chem., October 1, 2004; 279(40): 42221 - 42229. [Abstract] [Full Text] [PDF]

				K. E. King, V. P. Iyemere, P. L. Weissberg, and C. M. Shanahan Kruppel-like Factor 4 (KLF4/GKLF) Is a Target of Bone Morphogenetic Proteins and Transforming Growth Factor beta 1 in the Regulation of Vascular Smooth Muscle Cell Phenotype J. Biol. Chem., March 21, 2003; 278(13): 11661 - 11669. [Abstract] [Full Text] [PDF]

				N. Kalinina, A. Agrotis, E. Tararak, Y. Antropova, P. Kanellakis, O. Ilyinskaya, M. T. Quinn, V. Smirnov, and A. Bobik Cytochrome b558-Dependent NAD(P)H Oxidase-Phox Units in Smooth Muscle and Macrophages of Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 2037 - 2043. [Abstract] [Full Text] [PDF]

				M. R. Ward, A. Agrotis, P. Kanellakis, J. Hall, G. Jennings, and A. Bobik Tranilast Prevents Activation of Transforming Growth Factor-{beta} System, Leukocyte Accumulation, and Neointimal Growth in Porcine Coronary Arteries After Stenting Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 940 - 948. [Abstract] [Full Text] [PDF]

				M. R. Ward, P. S. Tsao, A. Agrotis, R. J. Dilley, G. L. Jennings, and A. Bobik Low Blood Flow After Angioplasty Augments Mechanisms of Restenosis : Inward Vessel Remodeling, Cell Migration, and Activity of Genes Regulating Migration Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 208 - 213. [Abstract] [Full Text] [PDF]

				X. Ma, M. Labinaz, J. Goldstein, H. Miller, W. J. Keon, M. Letarte, and E. O'Brien Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-{beta}-Induced Inhibition of Smooth Muscle Cell Migration Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2546 - 2552. [Abstract] [Full Text] [PDF]

				M. Sajid, M. Lele, and G. A. Stouffer Autocrine thrombospondin partially mediates TGF-beta 1- induced proliferation of vascular smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2159 - H2165. [Abstract] [Full Text] [PDF]

				L. R. James, I. G. Fantus, H. Goldberg, H. Ly, and J. W. Scholey Overexpression of GFAT activates PAI-1 promoter in mesangial cells Am J Physiol Renal Physiol, October 1, 2000; 279(4): F718 - F727. [Abstract] [Full Text] [PDF]

				H. Ueno, P. Kanellakis, A. Agrotis, and A. Bobik Blood Flow Regulates the Development of Vascular Hypertrophy, Smooth Muscle Cell Proliferation, and Endothelial Cell Nitric Oxide Synthase in Hypertension Hypertension, July 1, 2000; 36(1): 89 - 96. [Abstract] [Full Text] [PDF]

				C. M. Ford, S. Li, and J. G. Pickering Angiotensin II Stimulates Collagen Synthesis in Human Vascular Smooth Muscle Cells : Involvement of the AT1 Receptor, Transforming Growth Factor-{beta}, and Tyrosine Phosphorylation Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1843 - 1851. [Abstract] [Full Text] [PDF]

				L. M. Khachigian, F. S. Santiago, L. A. Rafty, O. L.-W. Chan, G. J. Delbridge, A. Bobik, T. Collins, and A. C. Johnson GC Factor 2 Represses Platelet-Derived Growth Factor A-Chain Gene Transcription and Is Itself Induced by Arterial Injury Circ. Res., June 11, 1999; 84(11): 1258 - 1267. [Abstract] [Full Text] [PDF]

				A. Bobik, A. Agrotis, P. Kanellakis, R. Dilley, A. Krushinsky, V. Smirnov, E. Tararak, M. Condron, and G. Kostolias Distinct Patterns of Transforming Growth Factor-ß Isoform and Receptor Expression in Human Atherosclerotic Lesions : Colocalization Implicates TGF-ß in Fibrofatty Lesion Development Circulation, June 8, 1999; 99(22): 2883 - 2891. [Abstract] [Full Text] [PDF]

				J. D. Smith, S. R. Bryant, L. L. Couper, C. P. H. Vary, P. J. Gotwals, V. E. Koteliansky, and V. Lindner Soluble Transforming Growth Factor-ß Type II Receptor Inhibits Negative Remodeling, Fibroblast Transdifferentiation, and Intimal Lesion Formation But Not Endothelial Growth Circ. Res., May 28, 1999; 84(10): 1212 - 1222. [Abstract] [Full Text] [PDF]

				P. Bray, A. Agrotis, and A. Bobik Transforming Growth Factor-ß and Receptor Tyrosine Kinase–Activating Growth Factors Negatively Regulate Collagen Genes in Smooth Muscle of Hypertensive Rats Hypertension, April 1, 1998; 31(4): 986 - 994. [Abstract] [Full Text] [PDF]